Zhuang X - Search Results

1

An engineered IL-2 partial agonist promotes CD8⁺ T cell stemness.

Mo F, Yu Z, Li P, Oh J, Spolski R, Zhao L, Glassman CR, Yamamoto TN, Chen Y, Golebiowski FM, Hermans D, Majri-Morrison S, Picton LK, Liao W, Ren M, Zhuang X, Mitra S, Lin JX, Gattinoni L, Powell JD, Restifo NP, Garcia KC, Leonard WJ. Mo F, et al. Among authors: zhuang x. Nature. 2021 Sep;597(7877):544-548. doi: 10.1038/s41586-021-03861-0. Epub 2021 Sep 15. Nature. 2021. PMID: 34526724 Free PMC article.

2

Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells.

Zhuang X, Woods J, Ji Y, Scheich S, Mo F, Rajagopalan S, Coulibaly ZA, Voss M, Urlaub H, Staudt LM, Pan KT, Long EO. Zhuang X, et al. Cell Rep. 2024 Apr 23;43(4):114105. doi: 10.1016/j.celrep.2024.114105. Epub 2024 Apr 14. Cell Rep. 2024. PMID: 38619967 Free article.

3

Inhibition-Resistant CARs for NK Cell Cancer Immunotherapy.

Zhuang X, Long EO. Zhuang X, et al. Trends Immunol. 2019 Dec;40(12):1078-1081. doi: 10.1016/j.it.2019.10.004. Epub 2019 Nov 12. Trends Immunol. 2019. PMID: 31732285 Review.

4

CRISPR Screen to Identify Factors that Render Tumor Cells Sensitive or Resistant to Killing by NK Cells.

Zhuang X, Long EO. Zhuang X, et al. Methods Mol Biol. 2022;2463:269-288. doi: 10.1007/978-1-0716-2160-8_19. Methods Mol Biol. 2022. PMID: 35344181

5

NK Cells Equipped With a Chimeric Antigen Receptor That Overcomes Inhibition by HLA Class I for Adoptive Transfer of CAR-NK Cells.

Zhuang X, Long EO. Zhuang X, et al. Front Immunol. 2022 May 2;13:840844. doi: 10.3389/fimmu.2022.840844. eCollection 2022. Front Immunol. 2022. PMID: 35585985 Free PMC article.

6

Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-γ.

Zhuang X, Veltri DP, Long EO. Zhuang X, et al. Front Immunol. 2019 Dec 11;10:2879. doi: 10.3389/fimmu.2019.02879. eCollection 2019. Front Immunol. 2019. PMID: 31921143 Free PMC article.

7

CD28 Homolog Is a Strong Activator of Natural Killer Cells for Lysis of B7H7⁺ Tumor Cells.

Zhuang X, Long EO. Zhuang X, et al. Cancer Immunol Res. 2019 Jun;7(6):939-951. doi: 10.1158/2326-6066.CIR-18-0733. Epub 2019 Apr 24. Cancer Immunol Res. 2019. PMID: 31018957 Free PMC article.

8

Complement factor P: promoting the antibacterial activity of natural killer cells.

Zhuang X, Long EO. Zhuang X, et al. Cell Mol Immunol. 2017 Oct;14(10):797-799. doi: 10.1038/cmi.2017.60. Epub 2017 Jul 24. Cell Mol Immunol. 2017. PMID: 28737740 Free PMC article. No abstract available.

9

Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy.

Phelan JD, Scheich S, Choi J, Wright GW, Häupl B, Young RM, Rieke SA, Pape M, Ji Y, Urlaub H, Bolomsky A, Doebele C, Zindel A, Wotapek T, Kasbekar M, Collinge B, Huang DW, Coulibaly ZA, Morris VM, Zhuang X, Enssle JC, Yu X, Xu W, Yang Y, Zhao H, Wang Z, Tran AD, Shoemaker CJ, Shevchenko G, Hodson DJ, Shaffer AL 3rd, Staudt LM, Oellerich T. Phelan JD, et al. Among authors: zhuang x. Cancer Cell. 2024 Feb 12;42(2):238-252.e9. doi: 10.1016/j.ccell.2023.12.019. Epub 2024 Jan 11. Cancer Cell. 2024. PMID: 38215749

10

Elastic films of single-crystal two-dimensional covalent organic frameworks.

Yang Y, Liang B, Kreie J, Hambsch M, Liang Z, Wang C, Huang S, Dong X, Gong L, Liang C, Lou D, Zhou Z, Lu J, Yang Y, Zhuang X, Qi H, Kaiser U, Mannsfeld SCB, Liu W, Gölzhäuser A, Zheng Z. Yang Y, et al. Among authors: zhuang x. Nature. 2024 May 8. doi: 10.1038/s41586-024-07505-x. Online ahead of print. Nature. 2024. PMID: 38718837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,242 results

Search Page